Status:
COMPLETED
Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults
Lead Sponsor:
Tor Biering-Sørensen
Conditions:
Influenza
Behavior and Behavior Mechanisms
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortal...
Detailed Description
The study is a prospective, randomized, open-label implementation trial. The study population will consist of persons aged \>=65 years at January 15, 2024 - this age group is eligible for free-of-char...
Eligibility Criteria
Inclusion
- Age \>=65 years at January 15, 2024 (eligible for free-of-charge influenza vaccination in the Danish public health system)
- Access to the official, mandatory Danish electronic mailbox system
Exclusion
- Persons living in nursing homes (approximated as any person living at an address with \>=6 inhabitants aged 80 years and above)
- Known to have already scheduled influenza vaccination appointment
Key Trial Info
Start Date :
September 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
881373 Patients enrolled
Trial Details
Trial ID
NCT06030726
Start Date
September 14 2023
End Date
May 31 2024
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
Hellerup, Capital Region, Denmark, 2900